GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hana Pharm Co Ltd (XKRX:293480) » Definitions » EBITDA Margin %

Hana Pharm Co (XKRX:293480) EBITDA Margin % : 10.13% (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Hana Pharm Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Hana Pharm Co's EBITDA for the three months ended in Sep. 2024 was ₩5,797 Mil. Hana Pharm Co's Revenue for the three months ended in Sep. 2024 was ₩57,250 Mil. Therefore, Hana Pharm Co's EBITDA margin for the quarter that ended in Sep. 2024 was 10.13%.


Hana Pharm Co EBITDA Margin % Historical Data

The historical data trend for Hana Pharm Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hana Pharm Co EBITDA Margin % Chart

Hana Pharm Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial 23.52 18.92 21.21 17.93 15.45

Hana Pharm Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.03 12.76 17.02 12.19 10.13

Competitive Comparison of Hana Pharm Co's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Hana Pharm Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hana Pharm Co's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hana Pharm Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Hana Pharm Co's EBITDA Margin % falls into.



Hana Pharm Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Hana Pharm Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=34678.17/224456.851
=15.45 %

Hana Pharm Co's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=5796.569/57250.049
=10.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hana Pharm Co  (XKRX:293480) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Hana Pharm Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Hana Pharm Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hana Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
218 Teheran-ro, 15 Floor, 16 Floor, Narae Building, Gangnam-gu, Seoul, KOR
Hana Pharm Co Ltd is a Korea based company engaged in drug development. It offers products for anesthetics, narcotic analgesics, antiemetics, antibiotics, dermatology, urinology, osteoporosis, and central nervous system.

Hana Pharm Co Headlines

No Headlines